Australian-New Zealand Clinical Trial: Psilocybin-Augmented Leadership Trial (PAL-001): Psilocybin-augmented professional development on social attitudes in politically engaged adults

Australia, Nov. 10 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Psilocybin-Augmented Leadership Trial (PAL-001): Psilocybin-augmented professional development on social attitudes in politically engaged adults’. The following are the other relevant details related to the trial:

Trial ID: 392359

Submit Date: 10/9/26 1:11

Study Type: Interventional

Intervention: PAL-001 is a randomised pilot trial of a psilocybin-augmented professional development program with group facilitation, designed to improve interpersonal functioning in potically engaged adults. The program runs over 13 weeks and has two components. Structured group facilitation program: three blocks of in-person ...